These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19807660)

  • 1. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas.
    Siddiqi S; Mills J; Matushansky I
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):63-73. PubMed ID: 19807660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferases inhibitors effectively induce gene expression changes suggestive of cardiomyogenic differentiation of human amniotic fluid-derived mesenchymal stem cells via chromatin remodeling.
    Gasiūnienė M; Zentelytė A; Wojtas B; Baronaitė S; Krasovskaja N; Savickienė J; Gielniewski B; Kaminska B; Utkus A; Navakauskienė R
    J Tissue Eng Regen Med; 2019 Mar; 13(3):469-481. PubMed ID: 30637987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigenomics of sarcoma.
    Nacev BA; Jones KB; Intlekofer AM; Yu JSE; Allis CD; Tap WD; Ladanyi M; Nielsen TO
    Nat Rev Cancer; 2020 Oct; 20(10):608-623. PubMed ID: 32782366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alterations in amniotic fluid mesenchymal stem cells derived from normal and fetus-affected gestations: A focus on myogenic and neural differentiations.
    Gasiūnienė M; Zentelytė A; Treigytė G; Baronaitė S; Savickienė J; Utkus A; Navakauskienė R
    Cell Biol Int; 2019 Mar; 43(3):299-312. PubMed ID: 30635962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in mesenchymal stem cells differentiation.
    Mortada I; Mortada R
    Eur J Med Genet; 2018 Feb; 61(2):114-118. PubMed ID: 29079547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign mesenchymal stromal cells in human sarcomas.
    Morozov A; Downey RJ; Healey J; Moreira AL; Lou E; Franceschino A; Dogan Y; Leung R; Edgar M; LaQuaglia M; Maki RG; Moore MA
    Clin Cancer Res; 2010 Dec; 16(23):5630-40. PubMed ID: 21138865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis.
    Bennani-Baiti IM
    Epigenomics; 2011 Dec; 3(6):715-32. PubMed ID: 22126291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
    Ramakrishnan S; Pili R
    Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.
    Gjerstorff M; Burns JS; Nielsen O; Kassem M; Ditzel H
    Am J Pathol; 2009 Jul; 175(1):314-23. PubMed ID: 19498007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.
    Ali D; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
    Stem Cells Transl Med; 2016 Aug; 5(8):1036-47. PubMed ID: 27194745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.
    Curylova L; Ramos H; Saraiva L; Skoda J
    Cancer Lett; 2022 Jan; 525():131-145. PubMed ID: 34742870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hiwi mediated tumorigenesis is associated with DNA hypermethylation.
    Siddiqi S; Terry M; Matushansky I
    PLoS One; 2012; 7(3):e33711. PubMed ID: 22438986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic approaches to regeneration of bone and cartilage from stem cells.
    Im GI; Shin KJ
    Expert Opin Biol Ther; 2015 Feb; 15(2):181-93. PubMed ID: 25283749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.
    McBride MJ; Kadoch C
    J Pathol; 2018 Apr; 244(5):638-649. PubMed ID: 29359803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoma Stem Cell Heterogeneity.
    Hatina J; Kripnerova M; Houfkova K; Pesta M; Kuncova J; Sana J; Slaby O; Rodríguez R
    Adv Exp Med Biol; 2019; 1123():95-118. PubMed ID: 31016597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation and PTEN activation in dental pulp mesenchymal stem cells promotes osteogenesis and reduces oncogenesis.
    Shen WC; Lai YC; Li LH; Liao K; Lai HC; Kao SY; Wang J; Chuong CM; Hung SC
    Nat Commun; 2019 May; 10(1):2226. PubMed ID: 31110221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter DNA methylation patterns of differentiated cells are largely programmed at the progenitor stage.
    Sørensen AL; Jacobsen BM; Reiner AH; Andersen IS; Collas P
    Mol Biol Cell; 2010 Jun; 21(12):2066-77. PubMed ID: 20410135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epigenetic mechanism of cardiac differentiation of stem cells].
    Zhu H; Liu Y; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1217-21. PubMed ID: 22246356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
    Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
    Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.